Fondaparinux: Protection Against Post-Surgical Blood Clots
by Karen Schroeder Kassel, MS, RD, MEd
Fondaparinux is a blood thinner used to prevent blood clots from forming.
When a blood clot forms in a vein in the legs, it is called deep vein thrombosis (DVT). DVT can block blood flow through the vein. Symptoms include pain, swelling, warmth, and a change in skin color of the affected leg. Sometimes, symptoms do not occur unless a clot breaks loose and travels through the bloodstream to the lungs. This is called pulmonary embolism and can be fatal. People who undergo certain surgeries are at high risk of developing DVT.
When Is Fondaparinux Prescribed?
Your doctor may prescribe fondaparinux after certain types of surgery, including hip or knee replacement, hip fracture repair, or abdominal surgery. This medication may be prescribed to people who are very ill and have risk factors for blood clots. Fondaparinux may also be used along with other blood thinners to treat DVT and pulmonary embolism.
How Is Fondaparinux Given?
This medication is given as an injection under the skin.
What Are the Side Effects?
Fondaparinux can cause many side effects. Some of these include:
Who Should Not Take This Medication?
Like all blood-thinning drugs, fondaparinux can cause excessive, dangerous bleeding. The risk of bleeding is greater for certain groups of people. You will not be able to take fondaparinux if you have any of these conditions:
What Are the Precautions With This Medication?
If you are prescribed fondaparinux:
In rare cases, you may be more likely to have severe bleeding after certain procedures, including:
National Heart, Lung, and Blood Institute
US Food & Drug Administration
Public Health Agency of Canada
Bauer, KA, Eriksson, BI, Lassen, MR, Turpie AG, Steering Committee of the Pentasaccharide in Major Knee Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med. 2001;345(18):1305-1310.
Deep vein thrombosis (DVT). EBSCO DynaMed Plus website. Available at: http://www.dynamed.... Updated July 29, 2016. Accessed April 11, 2017.
Eriksson, BI, Bauer, KA, Lassen, MR, Turpie AG, Steering Committee of the Pentasaccharide in Major Knee Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med. 2001;345(18):1298-1304.
Explore deep vein thrombosis. National Heart, Lung, and Blood Institute website. Available at: https://www.nhlbi.nih.gov/health/health-topics/topics/dvt. Updated October 28, 2011. Accessed April 11, 2017.
Fondaparinux. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T232869/Fondaparinux. Updated March 6, 2017. Accessed April 11, 2017.
Fondaparinux sodium. Daily Med—US National Library of Medicine website. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49e0d7bc-3f49-849b-c77c-98682d1c0d19. Updated March 25, 2016. Accessed April 11, 2017.
Risk factors for venous thromboembolism. EBSCO DynaMed Plus website. Available at: http://www.dynamed.... Updated January 15, 2017. Accessed April 11, 2017.
Last reviewed April 2017 by Michael Woods, MD, FAAP
Last Updated: 4/11/2017
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.